Cell therapy in gastroenterology

Home/2015, Vol. 3, No. 1/Cell therapy in gastroenterology

Cell and Organ Transplantology. 2015; 3(1):78-81.
DOI: 10.22494/COT.V3I1.25

Cell therapy in gastroenterology

Nasadyuk C. M.
Danylo Halitsky Lviv National Medical University, Lviv, Ukraine

Abstract
The article highlights the up-to-date literary data about the role of tissue and circulating stem cells in the processes of regeneration and carcinogenesis of gastric mucosa and intestine and development of liver and pancreatic fibrosis. The paper also presents the novel methods of treatment of common gastrointestinal diseases with the use of cell and gene technologies.

Keywords: stem cells; regenerative therapy; gastrointestinal tract

Full Text PDF

1. Denisova TP, Shuldyakov VA, Tyultyaeva LA, et al. Monitoring rasprostranennosti zabolevanij vnutrennih organov na primere patologii pishhevaritel’noj sistemy [Monitoring the incidence of diseases of the internal organs on the example of the pathology of the digestive system]. Saratovskij nauchno-medicinskij zhurnal – Saratov Journal of Medical Scientific. 2011; 4:772-776.
3. Askarov MB. Multipotent mesenchymal stromal cells from autologous bone marrow accelerate regeneration of refractory gastric ulcers. Eksp. Klin. Gastroenterol. 2008; 4:52-54.
4. Bessède E, Dubus P, Mégraud F, et al. Helicobacter pylori infection and stem cells at the origin of gastric cancer. Oncogene. 2014. http://www.ncbi.nlm.nih.gov/pubmed/25043305.
5. Ciccocioppo R, Bernardo ME, Russo ML, et al. Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease. J. Pediatr. Gastroenterol. Nutr. 2013; 56(4):422-427.
https://doi.org/10.1097/MPG.0b013e318276a6a7
PMid:23531481
6. De Miguel MP, Fuentes-Julián S, Blázquez-Martínez A, et al. Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr. Mol. Med. 2012; 12(5):574-591.
https://doi.org/10.2174/156652412800619950
PMid:22515979
7. Deng X, Szabo S, Chen L, et al. New cell therapy using bone marrow-derived stem cells/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitis. Curr. Pharm. Des. 2011; 17(16):1643-1651.
https://doi.org/10.2174/138161211796197007
PMid:21548863
8. Dhama K, Chakraborty S, Mahima MY, et al. Novel and emerging therapies safeguarding health of humans and their companion animals: a review. Pak. J. Biol. Sci. 2013; 16(3):101-111.
https://doi.org/10.3923/pjbs.2013.101.111
PMid:24171271
9. Hoffmann W. Regeneration of the gastric mucosa and its glands from stem cells. Curr. Med. Chem. 2008; 15(29):3133-3144.
https://doi.org/10.2174/092986708786848587
PMid:19075658
10. Hommes DW, Duijvestein M, Zelinkova Z, et al. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn’s disease. J. Crohns Colitis. 2011; 5(6):543-549.
https://doi.org/10.1016/j.crohns.2011.05.004
PMid:22115372
11. Meng Hong-Bo, Gong Jian, Zhou Bo, et al. Therapeutic effect of human umbilical cord-derived mesenchymal stem cells in rat severe acute pancreatitis. Int. J. Clin. Exp. Pathol. 2013; 6(12): 2703-2712.
PMid:24294357 PMCid:PMC3843251
12. Ishkitiev N, Yaegaki K, Imai T, et al. Novel management of acute or secondary biliary liver conditions using hepatically-differentiated human dental pulp cells. Tissue Eng. Part A. 2014. http://www.ncbi.nlm.nih.gov/pubmed/25234861.
13. Kikuchi H, Yagi H, Hasegawa H, et al. Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer. J. Surg. Res. 2014; 190(1):134-143.
https://doi.org/10.1016/j.jss.2014.02.047
PMid:24679698
14. Kniazev OV, Parfenov AI, Ruchkina IN, et al. New possibilities for overcoming the secondary inefficiency of anti-cytokine therapy in patients with inflammatory bowel diseases. Ter. Arkh. 2013; 85(2):57-60.
PMid:23653941
15. Komori M, Tsuji S, Tsuji M, et al. Efficiency of bone marrow-derived cells in regeneration of the stomach after induction of ethanol-induced ulcers in rats. J. Gastroenterol. 2005; 40(6):591-599.
https://doi.org/10.1007/s00535-005-1593-0
PMid:16007393
16. Lanthier N, Rubbia-Brandt L, Spahr L. Liver progenitor cells and therapeutic potential of stem cells in human chronic liver diseases. Acta Gastroenterol Belg. 2013; 76(1):3-9.
PMid:23650775
17. Leggett CL, Gorospe EC, Lutzke L, et al. A new era: endoscopic tissue transplantation. Curr. Opin. Gastroenterol. 2013; 29(5): 495-500.
https://doi.org/10.1097/MOG.0b013e328363e3fd
PMid:23872488 PMCid:PMC3815665
18. Li L, Liu S, Xu Y, et al. Human umbilical cord-derived mesenchymal stem cells down regulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis. Pharmacology. 2013; 92(5): 257-64.
https://doi.org/10.1159/000354883
PMid:24280970
19. Liao X, Cheng An JY, Zhou QJ, et al. Therapeutic effect of autologous bone marrow-derived liver stem cells transplantation in hepatitis B virus-induced liver cirrhosis. Hepatogastroenterology. 2013; 60(123):406-409.
PMid:23178469
20. Liu G, Neumeister M, Reichensperger J, et al. Therapeutic potential of human adipose stem cells in a cancer stem cell-like gastric cancer cell model. Int. J. Oncol. 2013; 43(4):1301-1309.
https://doi.org/10.3892/ijo.2013.2039
21. Nasadyuk C, Sklyarov A. Thymohexin exhibits cytoprotective effect in experimental gastric lesions in rats both through the inhibition of inducible nitric oxide synthase and reduction of oxidative mucosal damage. Regul.Pept. 2013; 180:50-57.
https://doi.org/10.1016/j.regpep.2012.11.004
PMid:23201077
22. Nasadyuk CM. Stem Cell Therapy In The Treatment Of Inflammatory Bowel Disease. Gastroenterology&Hepatology: Open Access. 2014; 1(1):00006.
23. Peng SY, Chou CJ, Cheng PJ, et al. Therapeutic potential of amniotic-fluid-derived stem cells on liver fibrosis model in mice. Taiwan J. Obstet. Gynecol. 2014; 53(2):151-157.
https://doi.org/10.1016/j.tjog.2014.04.005
PMid:25017258
24. Qin T, Liu CJ, Zhang HW, et al. Effect of the IkBα mutant gene delivery to mesenchymal stem cells on rat chronic pancreatitis. Genet Mol Res. 2014; 13(1):371-385.
https://doi.org/10.4238/2014.January.21.5
PMid:24535864
25. Resnick IB, Barkats C, Shapira MY, et al. Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC). Am. J. Blood Res. 2013; 19(3):225-238.
26. Senju S, Koba C, Haruta M, et al. Application of iPS cell-derived macrophages to cancer therapy. Oncoimmunology. 2014; 1(3):e27927.
https://doi.org/10.4161/onci.27927
PMid:24800175 PMCid:PMC4008454
27. Tarnawski AS, Ahluwalia A. Molecular mechanisms of epithelial regeneration and neovascularization during healing of gastric and esophageal ulcers. Curr. Med. Chem. 2012; 19(1):16-27.
https://doi.org/10.2174/092986712803414088
PMid:22300072
28. Tarnawski AS. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci. 2005; 50(1):S24-33.
https://doi.org/10.1007/s10620-005-2803-6
PMid:16184417
29. Vacanti JP, Kulig KM. Liver cell therapy and tissue engineering for transplantation. Semin. Pediatr. Surg. 2014; 23(3):150-155.
https://doi.org/10.1053/j.sempedsurg.2014.05.001
PMid:24994529
30. Vainshtein JM, Kabarriti R, Mehta KJ, et al. Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2014; 15(89):786-803.
https://doi.org/10.1016/j.ijrobp.2014.02.017
PMid:24969793 PMCid:PMC4074358
31. van Deen W K, Oikonomopoulos A, Hommes DW. Stem cell therapy in inflammatory bowel disease: which, when and how? Curr. Opin. Gastroenterol. 2013; 29(4):384-390.
https://doi.org/10.1097/MOG.0b013e328361f763
PMid:23666365
32. Varon C, Dubus P, Mazurie F, et al. Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice. Gastroenterology. 2012; 142(2):281-291.
https://doi.org/10.1053/j.gastro.2011.10.036
PMid:22062361
33. Voswinkel J, Francois S, Gorin NC, et al. Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells. Immunol. Res. 2013; 56(2-3):241-248.
https://doi.org/10.1007/s12026-013-8397-8
PMid:23564182
34. Wan Z, You S, Rong Y, et al. CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure. Dig Dis Sci. 2013; 58(2):448-457.
https://doi.org/10.1007/s10620-012-2458-z
PMid:23095991
35. Watanabe S, Arimura Y, Nagaishi K, et al. Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors. J. Gastroenterol. 2014; 49(2):270-282.
https://doi.org/10.1007/s00535-013-0901-3
PMid:24217964
36. Yu L, Yang L, An W, et al. Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells. J. Cell Biochem. 2014; 115(4):697-711.
https://doi.org/10.1002/jcb.24711
PMid:24214799
37. Zhang Z, Lin H, Shi M, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J. Gastroenterol. Hepatol. 2012; 27(2):112-120.
https://doi.org/10.1111/j.1440-1746.2011.07024.x
PMid:22320928

Nasadyuk CM. Cell therapy in gastroenterology. Cell and Organ Transplantology. 2015; 3(1):78-81. doi: 10.22494/COT.V3I1.25

 

Creative Commons License
Is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.